Report cover image

United States Generic Drugs Market: Market Size, Forecast, Insights, and Competitive Landscape

Publisher Prodture
Published Sep 07, 2024
Length 132 Pages
SKU # PROD19314707

Description

United States Generic Drugs Market: Market Size, Forecast, Insights, and Competitive Landscape


The United States generic drugs market is expected to grow at a CAGR of around 9.3% during 2025-2034. This report on United States generic drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the United States generic drugs market by segmenting the market based on type, therapy area, drug delivery, and distribution channel. Also, detailed profiles of companies operating in the United States generic drugs market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Increasing Prevalence of Chronic Diseases
• Growth in Geriatric Population
• Increasing Investments in Advertising

Market Challenges

• Stringent Governmental Regulations
• Adverse Effects Associated With Drugs

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Type

• Unbranded
• Branded

Market by Therapy Area

• CNS
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others

Market by Drug Delivery

• Oral
• Injectable
• Dermal/Topical
• Inhalers

Market by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies

Table of Contents

132 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. United States Generic Drugs Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. United States Generic Drugs Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. United States Generic Drugs Market by Type
5.1. Introduction
5.2 Unbranded
5.3 Branded
6. United States Generic Drugs Market by Therapy Area
6.1 Introduction
6.2 CNS
6.3 Cardiovascular
6.4 Dermatology
6.5 Genitourinary/Hormonal
6.6 Respiratory
6.7 Rheumatology
6.8 Diabetes
6.9 Oncology
6.10 Others
7. United States Generic Drugs Market by Drug Delivery
7.1 Introduction
7.2 Oral
7.3 Injectable
7.4 Dermal/Topical
7.5 Inhalers
8. United States Generic Drugs Market by Distribution Channel
8.1 Introduction
8.2 Hospital Pharmacies
8.3 Retail Pharmacies
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1 Competitive Scenario
12.2 Company Profiles
12.2.1 Teva
12.2.2 Mylan
12.2.3 Actavis (Teva)
12.2.4 Sandoz (Novartis)
12.2.5 Sun Pharma
12.2.6 Par Pharmaceuticals (Endo Pharmaceuticals)
12.2.7 Lupin Pharmaceuticals
12.2.8 Dr Reddy’s
12.2.9 Hospira (Pfizer)
12.2.10 Baxter International Inc
12.2.11 GlaxoSmithKline Plc.
12.2.12 Eli Lilly and Company
12.2.13 ALLERGAN
12.2.14 STADA Arzneimittel AG
12.2.15 Abbott Laboratories
List of Figures
Figure 1: United States Generic Drugs Market (in US$ Million), 2020-2024
Figure 2: United States Generic Drugs Market by Type, 2024
Figure 3: United States Generic Drugs Market by Therapy Area, 2024
Figure 4: United States Generic Drugs Market by Drug Delivery, 2024
Figure 5: United States Generic Drugs Market by Distribution Channel, 2024
Figure 6: United States Generic Drugs Market (in US$ Million), 2025-2034
Figure 7: United States Generic Drugs Market by Type (in %), 2024 & 2034
Figure 8: United States Unbranded Generic Drugs Market (in US$ Million), 2020-2024
Figure 9: United States Unbranded Generic Drugs Market (in US$ Million), 2025-2034
Figure 10: United States Branded Generic Drugs Market (in US$ Million), 2020-2024
Figure 11: United States Branded Generic Drugs Market (in US$ Million), 2025-2034
Figure 12: United States Generic Drugs Market by Therapy Area (in %), 2024 & 2034
Figure 13: United States CNS Generic Drugs Market (in US$ Million), 2020-2024
Figure 14: United States CNS Generic Drugs Market (in US$ Million), 2025-2034
Figure 15: United States Cardiovascular Generic Drugs Market (in US$ Million), 2020-2024
Figure 16: United States Cardiovascular Generic Drugs Market (in US$ Million), 2025-2034
Figure 17: United States Dermatology Generic Drugs Market (in US$ Million), 2020-2024
Figure 18: United States Dermatology Generic Drugs Market (in US$ Million), 2025-2034
Figure 19: United States Genitourinary/Hormonal Generic Drugs Market (in US$ Million), 2020-2024
Figure 20: United States Genitourinary/Hormonal Generic Drugs Market (in US$ Million), 2025-2034
Figure 21: United States Respiratory Generic Drugs Market (in US$ Million), 2020-2024
Figure 22: United States Respiratory Generic Drugs Market (in US$ Million), 2025-2034
Figure 23: United States Rheumatology Generic Drugs Market (in US$ Million), 2020-2024
Figure 24: United States Rheumatology Generic Drugs Market (in US$ Million), 2025-2034
Figure 25: United States Diabetes Generic Drugs Market (in US$ Million), 2020-2024
Figure 26: United States Diabetes Generic Drugs Market (in US$ Million), 2025-2034
Figure 27: United States Oncology Generic Drugs Market (in US$ Million), 2020-2024
Figure 28: United States Oncology Generic Drugs Market (in US$ Million), 2025-2034
Figure 29: United States Others Generic Drugs Market (in US$ Million), 2020-2024
Figure 30: United States Others Generic Drugs Market (in US$ Million), 2025-2034
Figure 31: United States Generic Drugs Market by Drug Delivery (in %), 2024 & 2034
Figure 32: United States Oral Generic Drugs Market (in US$ Million), 2020-2024
Figure 33: United States Oral Generic Drugs Market (in US$ Million), 2025-2034
Figure 34: United States Injectable Generic Drugs Market (in US$ Million), 2020-2024
Figure 35: United States Injectable Generic Drugs Market (in US$ Million), 2025-2034
Figure 36: United States Dermal/Topical Generic Drugs Market (in US$ Million), 2020-2024
Figure 37: United States Dermal/Topical Generic Drugs Market (in US$ Million), 2025-2034
Figure 38: United States Inhalers Generic Drugs Market (in US$ Million), 2020-2024
Figure 39: United States Inhalers Generic Drugs Market (in US$ Million), 2025-2034
Figure 40: United States Generic Drugs Market by Distribution Channel (in %), 2024 & 2034
Figure 41: United States Hospital Pharmacies Generic Drugs Market (in US$ Million), 2020-2024
Figure 42: United States Hospital Pharmacies Generic Drugs Market (in US$ Million), 2025-2034
Figure 43: United States Retail Pharmacies Generic Drugs Market (in US$ Million), 2020-2024
Figure 44: United States Retail Pharmacies Generic Drugs Market (in US$ Million), 2025-2034
Figure 45: Market Value Chain
List of Tables
Table 1: United States Generic Drugs Market Portraiture
Table 2: United States Generic Drugs Market by Type (in US$ Million), 2024 & 2034
Table 3: United States Generic Drugs Market by Therapy Area (in US $ Million), 2024 & 2034
Table 4: United States Generic Drugs Market by Drug Delivery (in US $ Million), 2024 & 2034
Table 5: United States Generic Drugs Market by Distribution Channel (in US$ Million), 2024 & 2034
Table 6: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us